Sunday 8 November 2026 Export IDXG’s income statement to Excel — free account

Interpace Biosciences, Inc.

IDXG

Interpace Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.7 million, down 17.5% from fiscal 2024.

Revenue: −1.09%
EPS: +104.1%
Free cash flow: −92.1%

Quarter to June 2026, against a year earlier

Operating cash flow growth 5 yrs

7.00 0.00 0.00%

Follow IDXG

Alert me

Market cap: —
P/E: 0.3×
Fwd P/E: —
Dividend yield: —
F-score: 5/9
Altman Z: −6.72
Beneish M: 2.07
Dividend safety: n/a

Overview

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	5	5	6
ROE Full definition →		(11.50%)	243.97%	210.21%	221.93%
ROA Full definition →		25.58%	101.07%	98.74%	104.29%
ROIC Full definition →		0.00%	12.85%	10.33%	12.67%
Return on Tangible Assets Full definition →		70.57%	395.10%	323.25%	320.07%
Average Days of Receivables Full definition →		51.95	53.24	59.67	63.73
Free Cash Flow per Share Full definition →		4.42	5.68	0.98	0.74
Free Cash Flow Full definition →		3.91	5.03	4.45	4.10
Capital Expenditures Full definition →		(0.96)	(0.81)	(0.42)	(0.35)
Other line items
Cash ROIC Full definition →		347.73%	20.21%	17.31%	15.83%
Accounts Receivable Turnover Full definition →		6.32	5.46	4.93	5.34
Accounts Payable Turnover Full definition →		10.23	11.05	10.70	9.34
Inventory Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		32.34	24.58	21.64	43.32
Days of Inventory on Hand Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	5.62	6.67	5.22
Research and Development Expense of Revenue Full definition →		1.66%	1.66%	1.71%	1.64%
Selling, General and Administrative Expense of Revenue Full definition →		49.46%	50.10%	51.51%	50.58%
Share Based Compensation of Revenue Full definition →		0.25%	0.09%	0.07%	0.05%
Operating CF/Net income Full definition →		1.46	0.24	0.21	0.18
Depreciation/Fixed assets Full definition →		0.55	0.62	0.69	0.57
Capex/Depreciation Full definition →		(1.13)	(0.92)	(0.47)	(0.38)
Revenue per Share Full definition →		47.36	43.77	7.95	6.52
Operating CF per Share Full definition →		5.51	6.59	1.07	0.80
Capex per Share Full definition →		(1.09)	(0.91)	(0.09)	(0.06)
Capex to Sales Full definition →		0.02	0.02	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026

Stockrow Weekly